Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Tango Therapeutics Inc (NASDAQ: TNGX) was $7.72 for the day, up 0.65% from the previous closing price of $7.67. In other words, the price has increased by $0.65 from its previous closing price. On the day, 2.48 million shares were traded. TNGX stock price reached its highest trading level at $7.93 during the session, while it also had its lowest trading level at $7.49.
Ratios:
Our analysis of TNGX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.88 and its Current Ratio is at 8.88. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $11.
On July 17, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $19.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 23 ’25 when Third Rock Ventures IV, L.P. sold 477,401 shares for $10.15 per share. The transaction valued at 4,846,575 led to the insider holds 13,386,574 shares of the business.
Third Rock Ventures IV, L.P. bought 477,401 shares of TNGX for $3,594,830 on Oct 23 ’25. On Sep 25 ’25, another insider, Third Rock Ventures IV, L.P., who serves as the 10% Owner of the company, sold 500,000 shares for $8.02 each. As a result, the insider received 4,008,500 and left with 13,863,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNGX now has a Market Capitalization of 1039065664 and an Enterprise Value of 921017664. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.63 while its Price-to-Book (P/B) ratio in mrq is 5.38. Its current Enterprise Value per Revenue stands at 13.85 whereas that against EBITDA is -8.535.
Stock Price History:
The Beta on a monthly basis for TNGX is 1.76, which has changed by 0.99220777 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, TNGX has reached a high of $9.70, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -1.12%, while the 200-Day Moving Average is calculated to be 64.89%.
Shares Statistics:
TNGX traded an average of 2.82M shares per day over the past three months and 2935400 shares per day over the past ten days. A total of 111.57M shares are outstanding, with a floating share count of 78.40M. Insiders hold about 41.75% of the company’s shares, while institutions hold 63.71% stake in the company. Shares short for TNGX as of 1761868800 were 29388713 with a Short Ratio of 10.43, compared to 1759190400 on 33812698. Therefore, it implies a Short% of Shares Outstanding of 29388713 and a Short% of Float of 25.319999999999997.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.29 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.82 and -$0.92 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is -$1.27, with 6.0 analysts recommending between -$1.13 and -$1.51.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for TNGX’s current fiscal year. The highest revenue estimate was $62.4M, while the lowest revenue estimate was $62.38M, resulting in an average revenue estimate of $62.4M. In the same quarter a year ago, actual revenue was $42.07M
